Literature DB >> 26997787

Evaluation of the Van Herick Technique for Screening for Occludable Angles in an African Population.

Shibal Bhartiya1, Tarek Shaarawy2.   

Abstract

The current gold standard for screening for angle closure and adopting universal approaches to prophylaxis is the assessment of the anterior chamber (AC) angle by gonioscopy, a technique that has substantial interobserver variability and relies on subjective assessment. Slit-lamp estimation of the peripheral anterior chamber depth (ACD) by the Van Herick technique is a noncontact approach for estimating angle width and various authors have commented on its sensitivity and specificity as a screening tool for identifying narrow angles as well as angle closure.This case series draws attention to the fact that as many as 28 out of 36 (77.78%) seemingly open angles on Van Herick test were found to be potentially occludable angles on gonioscopy. Therefore, it may be concluded that gonioscopy is essential even in patients with deep peripheral ACs, before an occludable angle can be ruled out. How to cite this article: Bhartiya S, Shaarawy T. Evaluation of the Van Herick Technique for Screening for Occludable Angles in an African Population. J Current Glau Prac 2013;7(2):88-90.

Entities:  

Keywords:  Gonioscopy.; Occludable angles; Peripheral anterior chamber depth; Van Herick technique

Year:  2013        PMID: 26997787      PMCID: PMC4741174          DOI: 10.5005/jp-journals-10008-1142

Source DB:  PubMed          Journal:  J Curr Glaucoma Pract        ISSN: 0974-0333


  13 in total

1.  Anterior chamber depth measurement as a screening tool for primary angle-closure glaucoma in an East Asian population.

Authors:  J G Devereux; P J Foster; J Baasanhu; D Uranchimeg; P S Lee; T Erdenbeleig; D Machin; G J Johnson; P H Alsbirk
Journal:  Arch Ophthalmol       Date:  2000-02

2.  Usefulness of peripheral anterior chamber depth assessment in glaucoma screening.

Authors:  K Kashiwagi; T Tokunaga; A Iwase; T Yamamoto; S Tsukahara
Journal:  Eye (Lond)       Date:  2005-09       Impact factor: 3.775

3.  Screening techniques for angle-closure glaucoma in rural Taiwan.

Authors:  N G Congdon; H A Quigley; P T Hung; T H Wang; T C Ho
Journal:  Acta Ophthalmol Scand       Date:  1996-04

4.  Estimation of width of angle of anterior chamber. Incidence and significance of the narrow angle.

Authors:  W Van Herick; R N Shaffer; A Schwartz
Journal:  Am J Ophthalmol       Date:  1969-10       Impact factor: 5.258

5.  Epidemiology of angle-closure glaucoma: prevalence, clinical types, and association with peripheral anterior chamber depth in the Egna-Neumarket Glaucoma Study.

Authors:  L Bonomi; G Marchini; M Marraffa; P Bernardi; I De Franco; S Perfetti; A Varotto
Journal:  Ophthalmology       Date:  2000-05       Impact factor: 12.079

6.  The flashlight test and van Herick's test are poor predictors for occludable angles.

Authors:  R Thomas; T George; A Braganza; J Muliyil
Journal:  Aust N Z J Ophthalmol       Date:  1996-08

7.  Anatomical risk factors in primary angle-closure glaucoma. A ten year follow up survey based on limbal and axial anterior chamber depths in a high risk population.

Authors:  P H Alsbirk
Journal:  Int Ophthalmol       Date:  1992-09       Impact factor: 2.031

8.  Survey of glaucoma in an eye clinic in Ghana, West Africa.

Authors:  Leon W Herndon; Pratap Challa; Ben Ababio-Danso; John O Boateng; Bob Broomer; Philip Ridenhour; R Rand Allingham
Journal:  J Glaucoma       Date:  2002-10       Impact factor: 2.503

9.  The pattern of glaucoma in Menelik II Hospital Addis Ababa, Ethiopia.

Authors:  Fikru Melka; Bayuh Alemu
Journal:  Ethiop Med J       Date:  2006-04

10.  The anterior chamber angles in Nigerians.

Authors:  A O Ashaye
Journal:  Afr J Med Med Sci       Date:  2003-09
View more
  1 in total

1.  Non-contact tests for identifying people at risk of primary angle closure glaucoma.

Authors:  Anish Jindal; Irene Ctori; Gianni Virgili; Ersilia Lucenteforte; John G Lawrenson
Journal:  Cochrane Database Syst Rev       Date:  2020-05-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.